Paclitaxel Labatec 30 mg/5 ml

Paclitaxel Labatec 30 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 60228. The authorisation holder is Labatec Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 09 April 2010 and the authorisation is valid without a time limit. ATC code L01CD01 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 60228
  • ATC L01CD01
  • Synthetic medicines
Authorisation data
Authorisation number60228
NamePaclitaxel Labatec 30 mg/5 ml
Full namePaclitaxel Labatec 30 mg/5 ml, solution à diluer pour perfusion
Authorisation holderLabatec Pharma SA
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01CD01
First authorisation09 April 2010
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Paclitaxel Labatec 30 mg/5 ml, solution à diluer pour perfusionA09 April 2010
2Paclitaxel Labatec 100 mg/16.7 ml, solution à diluer pour perfusionA09 April 2010
3Paclitaxel Labatec 150 mg/25 ml, solution à diluer pour perfusionA09 April 2010
4Paclitaxel Labatec 300 mg/50 ml, solution à diluer pour perfusionA09 April 2010

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01CD0107.16.1.A
21Durchstechflasche(n)L01CD0107.16.1.A
31Durchstechflasche(n)L01CD0107.16.1.A
41Durchstechflasche(n)L01CD0107.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Paclitaxel Labatec 30 mg/5 ml authorised in Switzerland?

Yes. Paclitaxel Labatec 30 mg/5 ml is authorised by Swissmedic under authorisation number 60228, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Paclitaxel Labatec 30 mg/5 ml have?

Paclitaxel Labatec 30 mg/5 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Paclitaxel Labatec 30 mg/5 ml?

The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com